.jpg)
METHOD FOR THE PROGNOSIS OF PATIENTS SUFFERING FROM ATRIAL FIBRILLATION
Patent number:
EP21382416
No items found.
The present invention pertains to the medical field. Particularly, the present invention refers to a method for predicting the response of patients suffering from atrial fibrillation (AF) to catheter ablation treatment, or for the prognosis of patients suffering from AF.
Countries:
Spain
Regions:
Galicia
Centers:
SERVIZO GALEGO DE SAUDE, INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
SDG03: Good health and well-being
Applications
Nowadays there is not a method to characterize cardiomyopathies and to determine the occurrence of AF in patients undergoing atrial ablation. Previous studies have proposed anatomical evaluations, but their success in determining the occurrence of AF is limited. For this reason, strategies to reflect AF through biomarkers have recently emerged, but there is still conflicting evidence. This technology responds to an unmet medical need.
Comments